S. Brooks

发表

Therapeutic potential of dithiolethiones for hepatic diseases.

Sang -Geon Kim, S. Brooks, J. S. Brooks, 2009, Pharmacology & therapeutics.

Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs.

A. Levin, S. Brooks, S. Kazmer, 1996, Blood.

The surgical implications of estrophile protein estimations in carcinoma of the breast.

A. Walt, S. Brooks, A. Singhakowinta, 1976, Surgery.

Estrogen Receptor and Natural Course of Breast Cancer

H. Potter, V. Vaitkevicius, S. Brooks, 1976, Annals of surgery.

Effect of growth on the estrogen receptor levels in MCF-7 cells.

M. Battelli, S. Brooks, E. R. Hansen, 1984, Cancer research.

p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE.

G. Liu, S. Brooks, J. Schwartz, 1999, Biochemical and biophysical research communications.

Role of porcine endometrial estrogen sulfotransferase in progesterone mediated downregulation of estrogen receptor.

S. Brooks, D. Saunders, M. Lozon, 1989, Journal of steroid biochemistry.

Crystal structure, receptor binding, and gene regulation of 2- and 4-nitroestradiols

M. Hafner, S. Brooks, L. Polin, 1996, Steroids.

Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.

A. Schwartz, A. Wenzlaff, M. Cote, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1α activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effect

Young Woo Kim, Sang -Geon Kim, Mi-Ock Lee, 2009, Molecular Cancer Therapeutics.

Racial differences in breast cancer patients.

J. Russo, G. Swanson, M. Brennan, 1985, Journal of the National Cancer Institute.

A molecular modeling analysis of diethylstilbestrol conformations and their similarity to estradiol-17β

T. Wiese, D. Dukes, S. Brooks, 1995, Steroids.

Changes in the structure of the ligand or substitutions to AF2 residues in the estrogen receptor make independent contributions to coactivator sensitivity by SRC-1

S. Brooks, J. Schwartz, 1998, The Journal of Steroid Biochemistry and Molecular Biology.

Advances in Brief Estrogen Receptor Protects p 53 from Deactivation by Human Double Minute-2 1

S. Brooks, J. Schwartz, Guo-zhen Liu, 2000 .

Skeletal conformations and receptor binding of some 9,11-modified estradiols

S. Brooks, L. Polin, J. Horwitz, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

Binding, X-ray and NMR studies of the three A-ring isomers of natural estradiol.

S. Brooks, J. Horwitz, M. J. Heeg, 1990, Journal of steroid biochemistry.

Studies on type II progesterone receptor in MCF-7 cells

S. Brooks, C. Christensen, D. Saunders, 1988, Steroids.

Optimization of estrogen growth response in MCF-7 cells

T. Wiese, S. Brooks, L. Kral, 1992, In Vitro Cellular & Developmental Biology - Animal.

Estrogen receptor in a human cell line (MCF-7) from breast carcinoma.

H. Soule, S. Brooks, E. Locke, 1973, The Journal of biological chemistry.

Impaired hepatocyte survival and liver regeneration in Atm-deficient mice.

Y. A. Wang, Yaolin Wang, S. Brooks, 2005, Human molecular genetics.

Characteristics of the dextran-coated charcoal assay for estradiol receptor in breast cancer preparations.

S. Brooks, S. Shafie, 1979, The Journal of laboratory and clinical medicine.

The metabolism of steroid hormones in breast cancer: a reappraisal.

S. Brooks, 1976, Current topics in molecular endocrinology.

Clinical correlations of steroid receptors and male breast cancer.

W. McGuire, M. Lippman, J. Wittliff, 1980, Cancer research.

Metabolism of 17/j-Estradiol during Receptor-mediated Nuclear Migration in Breast Cancer Cells1

S. Brooks, E. Locke, A. Horn, 2006 .

Ligand structure influences autologous downregulation of estrogen receptor–alpha messenger RNA

M. Davis, S. Brooks, J. Vanderkuur, 1999, The Journal of Steroid Biochemistry and Molecular Biology.

Quantitative determination of nuclear estrogen receptors by an enzyme immunoassay: applicability and caveats.

S. Brooks, L. Kral, L. Doherty, 1988, Journal of steroid biochemistry.

Induction of porcine uterine estrogen sulfotransferase activity by progesterone.

S. Meyers, S. Brooks, C. Christensen, 1983, Biology of reproduction.

Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.

S. Brooks, E. R. Hansen, 1982, Cancer research.

The cyclic relationship of estrogen sulfurylation to the nuclear receptor level in human endometrial curettings.

S. Brooks, R. Tovar, B. A. Pack, 1979, The Journal of clinical endocrinology and metabolism.

Nuclear and cytosolic estrogen receptor in gilt endometrium throughout the estrous cycle.

S. Brooks, C. Christensen, B. A. Pack, 1978, Endocrinology.

Retinoic acid signaling is required for proper morphogenesis of mammary gland

Y. A. Wang, Yaolin Wang, S. Brooks, 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

Prognostic value of estrogen receptor determinations in patients with breast cancer.

P. Furmanski, S. Brooks, M. Rich, 1978, Cancer research.

Endocrine steroid sulfotransferases: steroid alcohol sulfotransferase from human breast carcinoma cell line MCF-7.

S. Brooks, J. Horwitz, J. Corombos, 1986, Journal of steroid biochemistry.

The metabolism and nuclear migration of estrogen in porcine uterus throughout the implantation process.

C. Brooks, S. Brooks, W. Dukelow, 1979, Biology of reproduction.

Cyclic activity of estrogen sulfotransferase in the gilt uterus.

S. Brooks, B. A. Pack, B. Pack, 1974, Endocrinology.

Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes.

G. Liu, S. Brooks, J. Schwartz, 1998, Biochemical and biophysical research communications.

Induction of tissue plasminogen activator mRNA and activity by structurally altered estrogens

M. Davis, S. Brooks, W. B. Butler, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

Differential induction of pS2 and cathepsin D mRNAs by structurally altered estrogens.

M. Hafner, S. Brooks, L. Kral, 1993, Biochemistry.

Effects of estradiol-17 beta analogues on activation of estrogen response element regulated chloramphenicol acetyltransferase expression.

M. Hafner, S. Brooks, J. Christman, 1993, Biochemistry.

Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors.

D. Hughes, S. Brooks, J. Horwitz, 1983, Cancer research.

IV. Synthesis and assay of analogs of adenosine 3',5'-diphosphate as inhibitors of bovine adrenal estrogen sulfotranferase.

H. Chung, S. Brooks, J. Horwitz, 1978, Biochimica et biophysica acta.

Quantitative collection of micro amounts of steroids from gas-liquid chromatography

S. Brooks, V. Godefroi, 1964 .

Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex.

T. Wiese, S. Brooks, J. Vanderkuur, 1993, Biochemistry.

Protein and nucleic acid synthesis in tissue fractions of rat skin.

E. Van Der Schueren, W. D. De Loecker, S. Brooks, 1971, Archives internationales de physiologie et de biochimie.

Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

J. Russo, H. Soule, S. Brooks, 1990, Cancer research.

Polyoma middle T antigen in HL-60 cells accelerates hematopoietic myeloid and monocytic cell differentiation.

S. Brooks, A. Yen, M. Forbes, 1998, Experimental cell research.

Studies on bovine adrenal estrogen sulfotransferase. V. Synthesis and assay of analogs of 3'-phosphoadenosine 5'-phosphosulfate as cosubstrates for estrogen sulfurylation.

S. Brooks, J. Horwitz, J. Rozhin, 1980, Biochimica et biophysica acta.

Specificity studies on bovine adrenal estrogen sulfotransferase.

S. Brooks, J. Rozhin, R. L. Soderstrom, 1974, The Journal of biological chemistry.

ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development.

H. Heng, C. Deng, Yaolin Wang, 2005, Cancer research.

Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6

S. Brooks, J. Christman, M. Pilat, 2005, Breast Cancer Research and Treatment.

Induction of murine leukemia and lymphoma by dominant negative retinoic acid receptor α

Yaolin Wang, A. Kakizuka, Y. Ishida, 2005, Molecular carcinogenesis.

Endocrine steroid sulfotransferases: porcine endometrial estrogen sulfotransferase.

M. Battelli, S. Brooks, J. Corombos, 1987, Journal of Steroid Biochemistry.

The prognostic value of estrogen receptor determinations in patients with primary breast cancer: An update

P. Furmanski, S. Brooks, D. Saunders, 1980, Cancer.

A-ring substituted estrogens as inhibitors of the MXT transplantable mammary ductal carcinoma.

T. Corbett, S. Brooks, J. Horwitz, 1987, Cancer research.

The steroid alcohol and estrogen sulfotransferases in rodent and human mammary tumors.

S. Brooks, D. V. Singh, E. Locke, 1975, Cancer research.

Role of sulfate conjugation in estrogen metabolism and activity.

S. Brooks, D. V. Singh, J. Žemlička, 1978, Journal of toxicology and environmental health.

Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies: variables associated with disease recurrence and survivorship.

J. Russo, M. Brennan, S. Brooks, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metabolism of estrogens and their sulfates in rat uterine minces.

S. Brooks, B. Pack, 1970, Endocrinology.

Human Breast Epithelial Cell Line, MCF-10 Isolation and Characterization of a Spontaneously Immortalized

Jose Russo, Charles M. McGrath, J. Russo, 2006 .

Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

J. Russo, H. Soule, S. Brooks, 1990, Cancer research.

Relation of tumor content of estrogen and progesteron receptors with response of patient to endocrine therapy

V. Vaitkevicius, S. Brooks, A. Singhakowinta, 1980, Cancer.

Estrogen receptor protects p53 from deactivation by human double minute-2.

G. Liu, S. Brooks, J. Schwartz, 2000, Cancer research.

Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.

Yaolin Wang, Jie Chen, S. Brooks, 2006, Carcinogenesis.

ATM is activated by mitotic stress and suppresses centrosome amplification in primary but not in tumor cells

Yaolin Wang, A. Raz, S. Brooks, 2006, Journal of cellular biochemistry.

Isolation and characterization of a breast progenitor epithelial cell line with robust DNA damage responses

Y. A. Wang, A. Raz, F. Miller, 2006, Breast Cancer Research and Treatment.

From ligand structure to biological activity: modified estratrienes and their estrogenic and antiestrogenic effects in MCF-7 cells

S. Brooks, D. F. Skafar, 2004, Steroids.

Molecular modeling of steroidal estrogens: Novel conformations and their role in biological activity

T. Wiese, S. Brooks, S. C. Brooks, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7).

S. Brooks, S. Shafie, 1977, Cancer research.

Nuclear Estrogen Receptor β in Lung Cancer: Expression and Survival Differences by Sex

H. Pass, A. Schwartz, S. Brooks, 2005, Clinical Cancer Research.

The effects of breast cancer chemotherapy on wound healing in the rat.

M. McGonigal, A. Ledgerwood, C. Lucas, 1987, The Journal of surgical research.

Estrogen receptors and responsiveness of advanced breast cancer to chemotherapy

S. Martino, V. Vaitkevicius, S. Brooks, 1980, Cancer.

Clinical application of estrogen receptor in breast cancer

V. Vaitkevicius, S. Brooks, A. Singhakowinta, 1980, Cancer.

Relationship between estrogen structure and conformational changes in estrogen receptor/DNA complexes

S. Brooks, L. Polin, J. Christman, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

Effect of A-ring isomers of estradiol-17β on gene products in MCF-7 cells

S. Brooks, J. Vanderkuur, 1994, Steroids.

Evaluation of the predictive power of progesterone receptor levels in primary breast cancer: a comparison with other criteria in 559 cases with a mean follow-up of 74.8 months. The Breast Cancer Prognostic Study Associates.

J. Russo, S. Brooks, H. Ownby, 1990, Henry Ford Hospital medical journal.

An RXR-selective analog attenuates the RAR alpha-selective analog-induced differentiation and non-G1-restricted growth arrest of NB4 cells.

S. Brooks, A. Yen, R. Sturgill, 1997, Experimental cell research.

Estrogen receptors and response of breast cancer to chemotherapy.

R. Simon, V. Vaitkevicius, M. Lippman, 1978, The New England journal of medicine.

Neutral mutations to three acidic AF2 residues in the mouse estrogen receptor confer agonist activity to A-ring isomers of estradiol

S. Brooks, J. Schwartz, 1997, The Journal of Steroid Biochemistry and Molecular Biology.

Tumor-associated prostaglandins in patients with primary breast cancer: Relationship to clinical parameters

J. Russo, M. Brennan, S. Brooks, 1982, Breast Cancer Research and Treatment.

ClinicalCorrelationsof SteroidReceptorsand MaleBreastCancer1

W. McGuire, M. Lippman, J. Wittliff, 1980 .

Interrupted pregnancy as an indicator of poor prognosis in T1, 2, N0, M0 primary breast cancer

S. Martino, J. Russo, M. Brennan, 2005, Breast Cancer Research and Treatment.

Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.

T. Wiese, S. Brooks, L. Polin, 1997, Journal of medicinal chemistry.

The conjugation of estrogen metabolites by liver slices.

S. Brooks, J. Horwitz, L. Horn, 1965, Biochimica et Biophysica Acta.

Hepatic sulfation of estrogen metabolites.

S. Brooks, L. Horn, 1971, Biochimica et biophysica acta.

ON THE FORMATION OF ESTROPROTEIN.

A. Loud, S. Brooks, J. Horwitz, 1963, Biochimica et biophysica acta.

Effect of various functional groups on the gas-liquid chromatographic behavior of the estratriene nucleus.

S. Brooks, L. Horn, 1968, Analytical biochemistry.

Metabolism of 17β-Estradiol during Receptor-mediated Nuclear Migration in Breast Cancer Cells

S. Brooks, E. Locke, L. Horn, 1978 .